Literature DB >> 11591733

Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy.

S M Drouin1, D B Corry, J Kildsgaard, R A Wetsel.   

Abstract

Asthma is a chronic disease of the lung resulting from airway obstruction. Although the initiating causes are not entirely clear, the airway inflammation in asthma is associated with Th2 lymphocytes and their cytokines, particularly IL-4, which play a prominent role in this disease by regulating airway hyperresponsiveness, eosinophil activation, and IgE synthesis. Historically, complement was not thought to contribute to the pathogenesis of asthma. However, using C3-deficient mice in an allergen-induced model of pulmonary allergy, we demonstrate that complement may impact key features of this disease. When challenged with allergen, mice deficient in C3 exhibit diminished airway hyperresponsiveness and lung eosinophilia. Furthermore, these mice also have dramatically reduced numbers of IL-4-producing cells and attenuated Ag-specific IgE and IgG1 responses. Collectively, these results demonstrate that C3-deficient mice have significantly altered allergic lung responses and indicate a role for the complement system in promoting Th2 effector functions in asthma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591733     DOI: 10.4049/jimmunol.167.8.4141

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  The future of asthma therapy: integrating clinical and experimental studies.

Authors:  David B Corry; Farrah Kheradmand
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  A protective role for the fifth complement component (c5) in allergic airway disease.

Authors:  Scott M Drouin; Meenal Sinha; Georgia Sfyroera; John D Lambris; Rick A Wetsel
Journal:  Am J Respir Crit Care Med       Date:  2006-01-26       Impact factor: 21.405

Review 3.  Complement activation pathways: a bridge between innate and adaptive immune responses in asthma.

Authors:  Marsha Wills-Karp
Journal:  Proc Am Thorac Soc       Date:  2007-07

Review 4.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

5.  Potassium humate inhibits complement activation and the production of inflammatory cytokines in vitro.

Authors:  Constance E Jansen van Rensburg; Pieter J Naude
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

Review 6.  Therapeutic potential of complement modulation.

Authors:  Eric Wagner; Michael M Frank
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

7.  Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins.

Authors:  Monali M Bera; Bao Lu; Thomas R Martin; Shun Cui; Lawrence M Rhein; Craig Gerard; Norma P Gerard
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

Review 8.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Association study of the C3 gene with adult and childhood asthma.

Authors:  Hiroki Inoue; Yoichi Mashimo; Makiko Funamizu; Naoki Shimojo; Koichi Hasegawa; Tomomitsu Hirota; Satoru Doi; Makoto Kameda; Akihiko Miyatake; Yoichi Kohno; Yoshitaka Okamoto; Mayumi Tamari; Akira Hata; Yoichi Suzuki
Journal:  J Hum Genet       Date:  2008-06-20       Impact factor: 3.172

Review 10.  Complement components as potential therapeutic targets for asthma treatment.

Authors:  Mohammad Afzal Khan; Mark R Nicolls; Besiki Surguladze; Ismail Saadoun
Journal:  Respir Med       Date:  2014-01-15       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.